Galante Chiara, Marichal Nicolás, Scarante Franciele Franco, Ghayad Litsa Maria, Shi Youran, Schuurmans Carol, Berninger Benedikt, Péron Sophie
Institute of Physiological Chemistry, University Medical Center Johannes Gutenberg University, Mainz, Germany.
Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
Front Neurosci. 2022 Dec 2;16:919462. doi: 10.3389/fnins.2022.919462. eCollection 2022.
The proneural transcription factor Achaete-scute complex-like 1 (Ascl1) is a major regulator of neural fate decisions, implicated both in neurogenesis and oligodendrogliogenesis. Focusing on its neurogenic activity, Ascl1 has been widely used to reprogram non-neuronal cells into induced neurons. , Ascl1 induces efficient reprogramming of proliferative astroglia from the early postnatal cerebral cortex into interneuron-like cells. Here, we examined whether Ascl1 can similarly induce neuronal reprogramming of glia undergoing proliferation in the postnatal mouse cerebral cortex . Toward this goal, we targeted cortical glia during the peak of proliferative expansion (i.e., postnatal day 5) by injecting a retrovirus encoding for Ascl1 into the mouse cerebral cortex. In contrast to the efficient reprogramming observed , Ascl1-transduced glial cells were converted into doublecortin-immunoreactive neurons only with very low efficiency. However, we noted a drastic shift in the relative number of retrovirus-transduced Sox10-positive oligodendrocyte progenitor cells (OPCs) as compared to glial fibrillary acidic protein (GFAP)-positive astrocytes. Genetic fate mapping demonstrated that this increase in OPCs was not due to Ascl1-mediated astrocyte-to-OPC fate conversion. Rather, EdU incorporation experiments revealed that Ascl1 caused a selective increase in proliferative activity of OPCs, but not astrocytes. Our data indicate that rather than inducing neuronal reprogramming of glia in the early postnatal cortex, Ascl1 is a selective enhancer of OPC proliferation.
神经前体转录因子achaete-scute复合体样蛋白1(Ascl1)是神经命运决定的主要调节因子,与神经发生和少突胶质细胞生成均有关联。聚焦于其神经发生活性,Ascl1已被广泛用于将非神经元细胞重编程为诱导神经元。例如,Ascl1能有效地将出生后早期大脑皮层的增殖性星形胶质细胞重编程为中间神经元样细胞。在此,我们研究了Ascl1是否能同样诱导出生后小鼠大脑皮层中正在增殖的胶质细胞发生神经元重编程。为实现这一目标,我们在增殖高峰期(即出生后第5天),通过向小鼠大脑皮层注射编码Ascl1的逆转录病毒来靶向皮层胶质细胞。与观察到的高效重编程相反,转导Ascl1的胶质细胞仅以极低效率转化为双皮质素免疫反应阳性神经元。然而,我们注意到,与胶质纤维酸性蛋白(GFAP)阳性星形胶质细胞相比,逆转录病毒转导的Sox10阳性少突胶质细胞前体细胞(OPC)的相对数量发生了急剧变化。遗传命运图谱显示,OPC数量的增加并非由于Ascl1介导的星形胶质细胞向OPC的命运转变。相反,EdU掺入实验表明,Ascl1导致OPC的增殖活性选择性增加,而星形胶质细胞则未增加。我们的数据表明,Ascl1并非诱导出生后早期皮层胶质细胞发生神经元重编程,而是OPC增殖的选择性增强剂。